Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin
- PMID: 21670379
- DOI: 10.1001/archinternmed.2011.224
Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin
Comment on
-
Metformin use and mortality among patients with diabetes and atherothrombosis.Arch Intern Med. 2010 Nov 22;170(21):1892-9. doi: 10.1001/archinternmed.2010.409. Arch Intern Med. 2010. PMID: 21098347
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical